The effects of L-Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double-blind, randomized, placebo-controlled trial

Yahyapoor, F; Sedaghat, A; feizi, A; Bagherniya, M; Pahlavani, N; Khadem-Rezaiyan, M; Safarian, M; Islam, MS; Zarifi, SH; Arabi, SM; Norouzy, A

The effects of L-Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double-blind, randomized, placebo-controlled trial

journal contribution

posted on 2024-06-06, 10:06 authored by F Yahyapoor, A Sedaghat, A feizi, M Bagherniya, N Pahlavani, M Khadem-Rezaiyan, M Safarian, MS Islam, SH Zarifi, SM Arabi, A Norouzy

The effects of L-Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double-blind, randomized, placebo-controlled trial

History

Journal

Clinical Nutrition ESPEN

Volume

49

Pagination

61-67

Location

Amsterdam, The Netherlands

ISSN

2405-4577

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Publisher

Elsevier

Usage metrics

Keywords

L-Carnitine Inflammation Supplement Critically ill patient Intensive care unit

The effects of L-Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double-blind, randomized, placebo-controlled trial

History

Journal

Volume

Pagination

Location

ISSN

Language

Publication classification

Publisher

Usage metrics

Categories

Keywords

Licence

Exports